(Q34767569)

English

Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo

scientific article published on November 25, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo (English)

1 reference

Europe PubMed Central

4 August 2017

stereoselectivity

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M. G. Vartanian

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838797

7 December 2022

C. P. Taylor

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838797

7 December 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

4 August 2017

25 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1838797

7 December 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0304394091900696?httpAccept=text/xml

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

https://api.elsevier.com/content/article/PII:0304394091900696?httpAccept=text/plain

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Neuroscience Letters

1 reference

Europe PubMed Central

4 August 2017

133

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

109-112

1 reference

Europe PubMed Central

4 August 2017

A new device for the rapid measurement of impaired motor function in mice

1

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds

2

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Neurobiology. Taking apart NMDA receptors

3

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site

4

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Glycine potentiates the NMDA response in cultured mouse brain neurons

5

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

6

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Anticonvulsant effects of phencyclidine-like drugs: relation to N-methyl-D-aspartic acid antagonism

7

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs

8

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage

9

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Quantitative assessment of neuroprotection against NMDA-induced brain injury.

10

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model

11

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor

12

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate

13

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-D-aspartate receptor complex

14

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes

15

1 reference

10.1016/0304-3940(91)90069-6

https://api.crossref.org/works/10.1016/0304-3940(91)90069-6

7 December 2022

Identifiers

10.1016/0304-3940(91)90069-6

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34767569&oldid=1785786699"